Assessing risk in pulmonary arterial hypertension: what we know, what we don't
- PMID: 28775053
- DOI: 10.1183/13993003.01353-2017
Assessing risk in pulmonary arterial hypertension: what we know, what we don't
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.Eur Heart J. 2018 Dec 14;39(47):4175-4181. doi: 10.1093/eurheartj/ehx257. Eur Heart J. 2018. PMID: 28575277
-
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.Eur Respir J. 2017 Aug 3;50(2):1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775047
-
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.Eur Respir J. 2017 Aug 3;50(2):1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775050
Similar articles
-
[PRIMARY PULMONARY ARTERIAL HYPERTENSION. APROPOS OF 8 PERSONAL OBSERVATIONS].Mal Cardiovasc. 1965;6:121-38. Mal Cardiovasc. 1965. PMID: 14318785 French. No abstract available.
-
Know your enemy: understanding the pathophysiology of pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L995-L997. doi: 10.1152/ajplung.00111.2020. Epub 2020 Apr 1. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32233788 Free PMC article. No abstract available.
-
Risk assessment in pulmonary arterial hypertension.Eur Respir J. 2018 Mar 29;51(3):1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29599117 No abstract available.
-
Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis.J Am Soc Echocardiogr. 2013 Jan;26(1):1-14. doi: 10.1016/j.echo.2012.10.009. Epub 2012 Nov 8. J Am Soc Echocardiogr. 2013. PMID: 23140849 Review.
-
Epidemiology of pulmonary arterial hypertension.Clin Chest Med. 2013 Dec;34(4):619-37. doi: 10.1016/j.ccm.2013.08.010. Epub 2013 Oct 18. Clin Chest Med. 2013. PMID: 24267294 Review.
Cited by
-
Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.PLoS One. 2020 Nov 11;15(11):e0241504. doi: 10.1371/journal.pone.0241504. eCollection 2020. PLoS One. 2020. PMID: 33175857 Free PMC article.
-
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Eur Respir J. 2019 Jun 5;53(6):1802004. doi: 10.1183/13993003.02004-2018. Print 2019 Jun. Eur Respir J. 2019. PMID: 30923187 Free PMC article. Clinical Trial.
-
Risk assessment in precapillary pulmonary hypertension: a comparative analysis.Respir Res. 2021 Jan 21;22(1):28. doi: 10.1186/s12931-021-01624-z. Respir Res. 2021. PMID: 33478493 Free PMC article.
-
Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension.Front Cardiovasc Med. 2021 May 7;8:650848. doi: 10.3389/fcvm.2021.650848. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34026869 Free PMC article.
-
The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.Curr Hypertens Rep. 2019 Apr 25;21(6):45. doi: 10.1007/s11906-019-0950-y. Curr Hypertens Rep. 2019. PMID: 31025123 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical